1st Circ. Says Apellis Disclosures Weren't 'Half-Truths'

By Craig Clough · August 19, 2026, 10:07 PM EDT

A First Circuit panel on Wednesday affirmed the dismissal of a securities fraud lawsuit accusing Apellis Pharmaceuticals and some of its top executives of misleading investors about the safety testing of...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Apellis Pharm., Inc. Securities Litigation

Case Number

25-1383

Court

Appellate - 1st Circuit

Nature of Suit

3850 Securities/Commodities/Exchange

Date Filed

April 22, 2025